NSEUpdatesDividend14h ago
Fortis Healthcare Limited
Updates
Fortis Healthcare Limited has informed the Exchange regarding 'Intimation on Tax Deduction at Source (TDS) / withholding tax on Dividend'. The company has recommended a final dividend of Rs. 1 per equity share for the financial year ended March 31, 2026, subject to the approval of the shareholders at the 30th Annual General Meeting scheduled to be held on August 11, 2026.
NSEPress ReleaseMgmt Change1d ago
Fortis Healthcare Limited
Press Release
Fortis Healthcare Limited has informed the Exchange regarding the appointment of Mr. Vijender Singh as Managing Director & Chief Executive Officer of Agilus Diagnostics Limited, a subsidiary of the Company.
NSECopy of Newspaper Publication3d ago
Fortis Healthcare Limited
Copy of Newspaper Publication
Fortis Healthcare Limited has informed the Exchange about the dispatch of 30th Annual General Meeting (AGM) notice and Annual Report for the financial year 2025-26 through video conferencing.
NSEUpdatesDividend4d ago
Fortis Healthcare Limited
Updates
Fortis Healthcare Limited has informed the Exchange regarding 'closure of Register of Members' and fixed the record date for the purpose of payment of final dividend for the financial year 2025-26 as Friday, July 24, 2026.
NSERecord DateDividend4d ago
Fortis Healthcare Limited
Record Date
Fortis Healthcare Limited has announced the record date for the payment of final dividend for the financial year 2025-26 as July 24, 2026.
NSEGeneral Updates4d ago
Fortis Healthcare Limited
General Updates
Fortis Healthcare Limited has informed the Exchange about General Updates, including the notice of the 30th Annual General Meeting (AGM) of the shareholders and the Annual Report for FY 2025-26, which can be accessed on the company's website.
NSEUpdatesESG4d ago
Fortis Healthcare Limited
Updates
Fortis Healthcare Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report (BRSR)' and has announced the 30th Annual General Meeting and Annual Report for the Financial Year 2025-2026.
NSEShareholders meetingResults4d ago
Fortis Healthcare Limited
Shareholders meeting
Fortis Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 11, 2026.
NSECopy of Newspaper Publication9 Jul 2026
Fortis Healthcare Limited
Copy of Newspaper Publication
Fortis Healthcare Limited has informed the Exchange about publishing a newspaper advertisement for its 30th Annual General Meeting (AGM) through video conferencing.
NSECertificate under SEBI (Depositories and Participants) Regulations, 20188 Jul 2026
Fortis Healthcare Limited
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Fortis Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the Quater ended June 30, 2026.
NSEAppointmentMgmt Change8 Jul 2026
Fortis Healthcare Limited
Appointment
Fortis Healthcare Limited has appointed Dr. Ashutosh Raghuvanshi as Managing Director & CEO for a further period of two years, effective from March 19, 2027, subject to shareholder approval.
NSEOutcome of Board MeetingMgmt Change8 Jul 2026
Fortis Healthcare Limited
Outcome of Board Meeting
Fortis Healthcare Limited has informed the Exchange regarding the re-appointment of Dr. Ashutosh Raghuvanshi as Managing Director (designated as Managing Director and Chief Executive Officer) for a further period of Two years effective from March 19, 2027.
NSEPress Release▲ PositiveExpansion3 Jul 2026
Fortis Healthcare Limited
Press Release
Fortis Healthcare has signed an Operations and Management (O&M) agreement with Dion Group for a 300-bed multi-specialty hospital in Cuttack, Odisha.
NSEDisclosure under SEBI Takeover RegulationsRegulatory3 Jul 2026
Fortis Healthcare Limited
Disclosure under SEBI Takeover Regulations
Northern TK Venture Pte. Ltd. has submitted a disclosure under SEBI Takeover Regulations, stating they held 235,295,895 equity shares of Fortis Healthcare Limited as of 31 March 2026 and have not made any encumbrance of shares during the financial year.